[Funding alert] Paris-based Deeptech Startup Spore.Bio Secures €8 Million in Pre-Seed Funding

The round also included participation from top-tier investors and angels with experience in industry, FMCG and AI, including EmergingTech Ventures, No Label Ventures, Famille C (Clarins Family Office), Better Angle, Mehdi Ghissassi (Google DeepMind), Roxane Varza (Station F) and more.

Read also - Estonia-based Ecobase Raises €2.5M Seed Funding

It will be used to accelerate the development and deployment of Spore.Bio’s AI-powered technology and grow its team.

The startup has built the world’s first device for detecting pathogens immediately, directly on the factory floor. The device uses advanced machine learning models to train its system to identify the concentration of bacteria in food, drink, pharmaceuticals and cosmetic products before alerting quality managers to the potential risks.

Read also - Metz-based i-Virtual Secures €3 Million in Funding

Spore.Bio’s funding round, which comes less than a year after launch is a testament to the startup’s mission and the team’s deep expertise, which is made up of 12 world-class scientists and engineers from across microbiology, machine learning, optics, photonics and chemometrics.

Amine Raji, CEO and co-founder of Spore.Bio said: "Our mission is to redefine microbiology and to bring 21st-century technology to an age-old problem. The risks around pathogens in FMCGs are only growing, causing needless suffering for families and detrimental effects on the reputations and finances of global companies. We’re changing the status quo with Spore.Bio by combining AI and our deep expertise in this space. We’re delighted to be working with such a respected group of investors too that have the technical and strategic backgrounds that will help us scale and grow Spore.Bio into a globally significant business.”

Julia Hawkins, general partner at LocalGlobe said: “Spore.Bio’s innovation is where photonics and AI meet the same level of bacterial detection as traditional methods, in real-time. It’s not just a technological advancement; it's a stride towards a safer, healthier society and a clear case of how AI can solve real, industrial problems. Every one of us, directly or indirectly, interacts with products from these industries. Making sure these products are free from harmful bacteria should therefore be a significant concern for us all. The expert team’s solution gives industry, manufacturers and consumers the confidence that their products are as safe as possible.”

About Spore.Bio

Spore.Bio is a deeptech startup behind the world’s first real-time pathogen detection device for factories. Founded in 2023 by Amine Raji (CEO), Maxime Mistretta (CTO) and Mohamed Tazi (COO), Spore.Bio’s technology cuts quality sampling times from 20 days to only minutes and can be done from the factory floor, to reduce recall rates, deaths and global scandals from pathogens in FMCG. The startup’s first prototype is currently in development and its investors include LocalGlobe, EmergingTech Ventures and NoLabel Ventures.

Read also - Lyon-based Axeleo Capital Secures €73 Million second Fund